Idorsia Pharmaceuticals Ltd: Idorsia appoints Roland Wandeler as Chief Executive Officer

Ad hoc announcement pursuant to Art. 53 LR Idorsia appoints Roland Wandeler as CEO - effective October 1, 2026 - an experienced biopharmaceutical executive combining scientific expertise with busin...